No-reflow - An ominous sign of cardiac dysfunction

Nature Reviews Cardiology

Volumn 7, Issue 9, 2010, Pages 480-482

  Magro, Michael ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT; HEPARIN; NITRIC OXIDE; TECHNETIUM 99M;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTIFICIAL EMBOLISM; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; COMPETITIVE INHIBITION; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; ECHOCARDIOGRAPHY; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION INJURY; SAPHENOUS VEIN GRAFT; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERAPY EFFECT; ACUTE CORONARY SYNDROME; AGED; ARTICLE; CONFIDENCE INTERVAL; FEMALE; HEART INFARCTION; HEART MUSCLE; INCIDENCE; MALE; MIDDLE AGED; PATHOLOGY; PERFUSION; RISK; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; ODDS RATIO; PERFUSION; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77956030745     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2010.117     Document Type: Short Survey

References (10)

1. ndrepepa, G. et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 55, 2383-2389 (2010).
2. Galiuto, L. et al. Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation. Heart 89, 731-737 (2003).
3. Angeja, B. G. et al. TiMi myocardial perfusion grade and sT-segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation 105, 282-285 (2002).
4. Francone, M. et al. impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with sT-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 54, 2145-2153 (2009).
5. iwakura, K. et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur. Heart J. 27, 534-539 (2006).
6. Dudek, D. et al. Patency of infarct related artery after pharmacological reperfusion during transfer to primary percutaneous coronary intervention influences left ventricular function and one-year clinical outcome. Int. J. Cardiol. 124, 326-331 (2008).
7. svilaas, T. et al. Thrombus aspiration during primary percutaneous coronary intervention. N. Engl. J. Med. 358, 557-567 (2008).
8. Aymong, e. D. et al. Abciximab attenuates coronary microvascular endothelial dysfunction after coronary stenting. Circulation 105, 2981-2985 (2002).
9. iwakura, K. et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J. Am. Coll. Cardiol. 38, 472-477 (2001).
10. Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121-1135 (2007).